Latest Regulatory Uncertainty News

Page 8 of 18
Elixinol Wellness Limited (ASX – EXL) has launched a substantial options offer to placement investors and its lead manager, pending shareholder approval. The offer could reshape the company’s capital structure and potentially raise $4.4 million upon exercise.
Ada Torres
Ada Torres
30 Oct 2025
CAQ Holdings reported a 7% drop in leasing revenue amid persistently high vacancy rates and cash flow pressures in the September 2025 quarter. The company is negotiating lease renewals and seeking debt facility extensions to sustain operations.
Eva Park
Eva Park
30 Oct 2025
Arovella Therapeutics reported solid progress in Q1 FY26, moving closer to initiating its first-in-human trial for ALA-101 while securing key patents and maintaining a strong cash position.
Ada Torres
Ada Torres
30 Oct 2025
Southern Palladium Limited has launched a Share Purchase Plan allowing eligible shareholders to invest up to $30,000 at $1.10 per share, aiming to raise $1 million to advance its Bengwenyama mine project in South Africa.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Equatorial Resources reports a postponed arbitration hearing over Congo iron ore disputes and seeks clarity on Guinea permit cancellations, while maintaining a solid cash reserve.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Lindian Resources secures official government confirmation that its Kangankunde Rare Earths Project is exempt from Malawi’s new raw mineral export ban, ensuring uninterrupted progress toward production.
Maxwell Dee
Maxwell Dee
29 Oct 2025
Triangle Energy (Global) Limited has secured three new permits in the Philippines, advancing its gas exploration portfolio while navigating joint venture withdrawals in Australia and finalising the sale of its Cliff Head onshore assets.
Maxwell Dee
Maxwell Dee
28 Oct 2025
ikeGPS Group reports a robust first half of FY26 with a 47% increase in subscription revenue exit run rate and launches AI-driven PolePilot™ to boost productivity and ARPU.
Sophie Babbage
Sophie Babbage
28 Oct 2025
Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.
Ada Torres
Ada Torres
23 Oct 2025
Woodside Energy has raised its 2025 production guidance following a 1% increase in quarterly output, while progressing key projects like Scarborough and Beaumont New Ammonia on schedule. The company also secured long-term LNG supply deals and received critical regulatory approvals.
Maxwell Dee
Maxwell Dee
22 Oct 2025
AMP Limited reports a 3.6% rise in total assets under management, driven by a 61.6% jump in Platforms net cashflows and steady growth across divisions, alongside significant legal settlements.
Claire Turing
Claire Turing
16 Oct 2025
Orpheus Uranium Limited has agreed to acquire the Oobagooma Uranium Project in Western Australia, unlocking significant historical uranium mineralisation and exploration potential in the Canning Basin.
Maxwell Dee
Maxwell Dee
14 Oct 2025